Gene therapy vectors hold promise to revolutionize treatment for many diseases, but also carry a risk of causing cancer if they integrate into oncogenic sites such as LMO2. Researchers at St. Jude
[更多]
Immune Cells with DNMT3A Gene Modifications (SJ-16-0009)Chemotherapy is the standard of care for the treatment of many types of cancer, but alternative methods are needed when chemotherapy is not ef
[更多]
| |< <- | [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] | -> >| |
